PA
EXK

PharVision Advisers’s Endeavour Silver EXK Stock Holding History

PharVision Advisers’s Portfolio EXK Stock Details EXK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.2K Buy
+10,290
New +$95.8K 1.61% 29
2026
Q1 		– Sell
-35,469
Closed -$333K – 286
2025
Q4 		$333K Buy
+35,469
New +$301K 0.17% 223

Other funds holding EXK

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CM
Condire Management Dallas, Texas $942M AUM 83.43% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

PharVision Advisers's EXK Position: Q2 2026 in Review

PharVision Advisers opened a new position in Endeavour Silver (EXK) in Q2 2026: 10,290 shares worth $85.2K. The stake represents 1.61% of the portfolio and ranks #29 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in EXK as recently as Q4 2025.

PharVision Advisers first reported a position in EXK in Q4 2025 and has held it in 2 quarters since. The position peaked at $333K in Q4 2025. 222 funds tracked by Wall St. Rank hold EXK as of Q2 2026.

  • PharVision Advisers held 10,290 shares of Endeavour Silver worth $85.2K as of Q2 2026.
  • Endeavour Silver was a new PharVision Advisers position in Q2 2026.
  • Endeavour Silver made up 1.61% of PharVision Advisers's portfolio in Q2 2026, its #29 holding.
  • PharVision Advisers first reported a position in Endeavour Silver in Q4 2025 and has held it in 2 quarters since.
  • PharVision Advisers's Endeavour Silver position peaked at $333K in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Endeavour Silver as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.